stem cells in drug discovery
BioNEt Event
Wednesday 27 April 2005, 10.15 am-3.30 pm, Lindisfarne Centre,
St Aidan's College, University of Durham. Refreshments, attendance and lunch are free. Limited to 70 participants. Register for event by emailing Dr Pamela Robinson at Enquiries
Stem Cells in Drug Discovery
Programme
10.15 Coffee and registration
Chair: Dr Stefan Przyborski, Biological and Biomedical Sciences, University of Durham
10.35 The drug discovery process
Dr Janette Thomas, Centre of Excellence for Life Sciences (CELS) Ltd, Newcastle
11.00 Essential characteristics of cell-based assays
Dr Morag Macfarlane, Scottish Biomedical, Glasgow
11.25 Role of stem cells in drug development
Dr Raj Chopra, AstraZeneca, Macclesfield
11.50 Stem cells for ADME/toxicity
Dr Andy Pike, Merck Sharp and Dohme, Harlow
12.15 Lunch
Chair: Prof Chris Hutchison, Biological and Biomedical Sciences, University of Durham
13.20 Stem cell applications to CNS: Understanding the molecular pathways
Dr Stefan Przyborski, Biological and Biomedical Sciences, University of Durham and ReInnervate Ltd, Durham
13.45 Rationale and approaches in neural stem cell assays for neurodegenerative diseases
Dr Aaron T.T. Chuang, GlaxoSmithKline plc, Harlow
14.10 Neural Stem cells as drug targets: Therapeutic neurogenesis
Dr Jarkko Kortesmaa, NeuroNova AB, Sweden
14.35 Regional stem cell technologies for drug discovery
Dr Carolyn Horrocks, Centre of Excellence for Life Sciences (CELS) Ltd, Newcastle
15.00 Tea
15.30 Close of workshop
Supported by BioNEt, CELS Ltd, European Regional Development Fund and EuroTech
|